2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Andrade Robert | — | 168,244 | Sep 2, 2025 |
| Raykov Rosty | Director | 87,293 | Sep 8, 2025 |
| Rallis Chris A | Director | 54,792 | Jul 7, 2025 |
| Hackman Jeffrey S. | CEO | 15,000 | May 19, 2025 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Sep 8, 2025 | Raykov Rosty | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2025 | Sep 4, 2025 | Raykov Rosty | Director | Sell | 20.0 | -10,000 | -16.37% | ✓ | $89.2K |
| Aug 31, 2025 | Sep 2, 2025 | Andrade Robert | CFO | Neutral | 77.5 | +2,431 | 1.47% | ✗ | - |
| Aug 31, 2025 | Sep 2, 2025 | Raykov Rosty | Director | Neutral | 85.0 | +5,208 | 9.32% | ✗ | - |
| Aug 5, 2025 | Aug 5, 2025 | Raykov Rosty | Director | Sell | 20.0 | -10,000 | -15.18% | ✓ | $80.9K |
| Jul 31, 2025 | Aug 1, 2025 | Raykov Rosty | Director | Neutral | 85.0 | +5,208 | 8.58% | ✗ | - |
| Jul 31, 2025 | Aug 1, 2025 | Andrade Robert | CFO | Neutral | 77.5 | +2,431 | 1.49% | ✗ | - |
| Jul 7, 2025 | Jul 7, 2025 | RALLIS CHRIS A | Director | Sell | 46.3 | -1,119 | -2.00% | ✓ | $9.7K |
| Jul 3, 2025 | Jul 7, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -14.15% | ✓ | $86.1K |
| Jun 30, 2025 | Jul 1, 2025 | Raykov Rosty | Director | Neutral | 85.0 | +5,208 | 7.96% | ✗ | - |
| Jun 30, 2025 | Jul 1, 2025 | Andrade Robert | CFO | Neutral | 77.5 | +2,431 | 1.51% | ✗ | - |
| Jun 5, 2025 | Jun 6, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -13.25% | ✓ | $77.8K |
| Jun 3, 2025 | Jun 4, 2025 | Cook Jodi A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | Brughera Marco Maria | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | RALLIS CHRIS A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2025 | Jun 4, 2025 | Islam Khalid | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 2, 2025 | Raykov Rosty | Director | Neutral | 85.0 | +5,208 | 7.41% | ✗ | - |
| May 31, 2025 | Jun 2, 2025 | Andrade Robert | CFO | Neutral | 77.5 | +2,431 | 1.53% | ✗ | - |
| May 22, 2025 | May 23, 2025 | Andrade Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 16, 2025 | May 19, 2025 | Hackman Jeffrey S. | CEO | Buy | 95.0 | +15,000 | 100.00% | ✗ | $104.6K |
| May 16, 2025 | May 19, 2025 | Raykov Rosty | Director | Sell | 95.0 | +16,667 | 31.10% | ✗ | $113K |
| May 16, 2025 | May 19, 2025 | Andrade Robert | CFO | Neutral | 90.0 | +16,667 | 12.47% | ✗ | - |
| May 5, 2025 | May 5, 2025 | Raykov Rosty | Director | Sell | 20.0 | -10,000 | -15.73% | ✓ | $63.1K |
| Apr 30, 2025 | May 1, 2025 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.79% | ✗ | - |
| Apr 30, 2025 | May 1, 2025 | Raykov Rosty | Director | Neutral | 82.5 | +2,431 | 3.98% | ✗ | - |
| Apr 11, 2025 | Apr 11, 2025 | RALLIS CHRIS A | Director | Sell | 46.3 | -1,409 | -2.55% | ✓ | $7K |
| Apr 4, 2025 | Apr 4, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -14.05% | ✓ | $52.5K |
| Mar 28, 2025 | Apr 3, 2025 | Cioffi Christiana Marie | Chief Strategy Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Sayad Pierre Sargis | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Evans Terry L | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Hackman Jeffrey S. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Andrade Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Hackman Jeffrey S. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Evans Terry L | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 28, 2025 | Apr 3, 2025 | Cioffi Christiana Marie | Chief Strategy Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 31, 2025 | Apr 1, 2025 | Raykov Rosty | Director | Neutral | 82.5 | +2,431 | 3.54% | ✗ | - |
| Mar 31, 2025 | Apr 1, 2025 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.79% | ✗ | - |
| Mar 5, 2025 | Mar 6, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -12.70% | ✓ | $67.9K |
| Feb 28, 2025 | Feb 28, 2025 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.80% | ✗ | - |
| Feb 28, 2025 | Feb 28, 2025 | Raykov Rosty | Director | Neutral | 82.5 | +2,431 | 3.19% | ✗ | - |
| Feb 14, 2025 | Feb 14, 2025 | RALLIS CHRIS A | Director | Sell | 46.3 | -1,186 | -2.19% | ✓ | $8.1K |
| Feb 5, 2025 | Feb 5, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -11.59% | ✓ | $66.6K |
| Jan 31, 2025 | Feb 3, 2025 | Raykov Rosty | Director | Neutral | 82.5 | +2,431 | 2.90% | ✗ | - |
| Jan 31, 2025 | Feb 3, 2025 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.80% | ✗ | - |
| Jan 6, 2025 | Jan 7, 2025 | Raykov Rosty | Director | Sell | 25.0 | -10,000 | -10.65% | ✓ | $60.8K |
| Dec 31, 2024 | Jan 3, 2025 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.81% | ✗ | - |
| Dec 31, 2024 | Jan 3, 2025 | Raykov Rosty | Director | Neutral | 82.5 | +2,431 | 2.66% | ✗ | - |
| Dec 20, 2024 | Dec 23, 2024 | Raykov Rosty | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 5, 2024 | Dec 5, 2024 | Raykov Rosty | Director | Sell | 50.0 | -796 | -1.18% | ✓ | $4.8K |
| Dec 2, 2024 | Dec 4, 2024 | Raykov Rosty | Director | Sell | 78.8 | +796 | 1.20% | ✓ | $10K |
| Dec 2, 2024 | Dec 2, 2024 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.82% | ✗ | - |
| Dec 2, 2024 | Dec 2, 2024 | RALLIS CHRIS A | Director | Sell | 28.8 | -6,409 | -10.93% | ✓ | $39.4K |
| Nov 18, 2024 | Nov 18, 2024 | Andrade Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 13, 2024 | Cioffi Christiana Marie | Chief Strategy Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 13, 2024 | Evans Terry L | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 13, 2024 | Sayad Pierre Sargis | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 31, 2024 | Nov 4, 2024 | Raykov Rosty | Director | Sell | 57.5 | - | 0.00% | ✓ | $10.5K |
| Oct 31, 2024 | Nov 4, 2024 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.94% | ✗ | - |
| Nov 4, 2024 | Cioffi Christiana Marie | Chief Strategy Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2024 | Evans Terry L | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2024 | Sayad Pierre Sargis | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 8, 2024 | Oct 10, 2024 | RALLIS CHRIS A | Director | Sell | 46.3 | -1,406 | -2.81% | ✓ | $6.4K |
| Sep 30, 2024 | Oct 1, 2024 | Andrade Robert | CFO | Neutral | 67.5 | +1,042 | 0.95% | ✗ | - |
| Sep 30, 2024 | Oct 1, 2024 | Raykov Rosty | Director | Sell | 57.5 | - | 0.00% | ✓ | $12K |